Literature DB >> 8454310

Distinct effects of bFGF and PDGF on oligodendrocyte progenitor cells.

R D McKinnon1, C Smith, T Behar, T Smith, M Dubois-Dalcq.   

Abstract

We have compared the effects of platelet-derived (PDGF) and basic fibroblast (bFGF) growth factors on the shape, migration, and differentiation of oligodendrocyte progenitor cells, the precursors of myelin-forming cells in the CNS. In the presence of bFGF, oligodendrocyte progenitors purified from rat neonatal brain cultures were stellate, non-motile, and had a morphological complexity of 1.26 +/- 0.03 as measured by fractal dimension (D). These cells expressed transcripts encoding the POU-homeodomain transcription factor Oct-6, but not myelin genes. Upon addition of PDGF, bFGF-treated cells became motile and twofold less complex in shape (D = 1.19 +/- 0.03). These changes occurred within 6 +/- 4 h and were dependent on de novo transcription and translation, but not DNA synthesis. Upon removal of PDGF the cells reverted to their stellate shape (D = 1.26). Removal of both bFGF and PDGF resulted in oligodendrocyte differentiation after 3 days, with a fourfold increase in complexity of shape (D = 1.55 +/- 0.08), loss of Oct-6 transcripts, and gain of myelin transcripts. Thus PDGF is both necessary and sufficient to induce a motile state in progenitor cells growing in the presence of bFGF. Together with our previous data (McKinnon et al.: Neuron 5:603, 1990), our results suggest that bFGF and PDGF may control distinct phases of proliferation and migration of oligodendrocyte progenitor cells in vivo.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8454310     DOI: 10.1002/glia.440070308

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  25 in total

1.  Cell-surface glycoprotein of oligodendrocyte progenitors involved in migration.

Authors:  A Niehaus; J Stegmüller; M Diers-Fenger; J Trotter
Journal:  J Neurosci       Date:  1999-06-15       Impact factor: 6.167

2.  Adult brain retains the potential to generate oligodendroglial progenitors with extensive myelination capacity.

Authors:  S C Zhang; B Ge; I D Duncan
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

Review 3.  From stem cells to oligodendrocytes: prospects for brain therapy.

Authors:  Cui P Chen; Mary E Kiel; Dorota Sadowski; Randall D McKinnon
Journal:  Stem Cell Rev       Date:  2007-12       Impact factor: 5.739

4.  Induction of human umbilical Wharton's jelly-derived stem cells toward oligodendrocyte phenotype.

Authors:  Elmira Mikaeili Agah; Kazem Parivar; Mohammad Nabiuni; Mehrdad Hashemi; Masoud Soleimani
Journal:  J Mol Neurosci       Date:  2013-09-11       Impact factor: 3.444

5.  A role in migration for the alpha V beta 1 integrin expressed on oligodendrocyte precursors.

Authors:  R Milner; G Edwards; C Streuli; C Ffrench-Constant
Journal:  J Neurosci       Date:  1996-11-15       Impact factor: 6.167

6.  The constitutive heat shock protein-70 is required for optimal expression of myelin basic protein during differentiation of oligodendrocytes.

Authors:  D A Aquino; D Peng; C Lopez; M Farooq
Journal:  Neurochem Res       Date:  1998-03       Impact factor: 3.996

7.  Cyclin dependent kinase 5 is required for the normal development of oligodendrocytes and myelin formation.

Authors:  Yan Yang; Haibo Wang; Jie Zhang; Fucheng Luo; Karl Herrup; James A Bibb; Richard Lu; Robert H Miller
Journal:  Dev Biol       Date:  2013-04-10       Impact factor: 3.582

Review 8.  Pathology and molecular genetics of oligodendroglial tumors.

Authors:  Christian Hartmann; Wolf Mueller; Andreas von Deimling
Journal:  J Mol Med (Berl)       Date:  2004-10       Impact factor: 4.599

9.  Promoting return of function in multiple sclerosis: An integrated approach.

Authors:  Mar Gacias; Patrizia Casaccia
Journal:  Mult Scler Relat Disord       Date:  2013-10-01       Impact factor: 4.339

10.  Neurotrophin-3 targets the translational initiation machinery in oligodendrocytes.

Authors:  Rochelle P Coelho; Larra M Yuelling; Babette Fuss; Carmen Sato-Bigbee
Journal:  Glia       Date:  2009-12       Impact factor: 7.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.